Adult-onset Still's disease after SARS-Cov-2 infection.
SARS‐CoV‐2
Still's disease
adult‐onset
autoimmune diseases
hyperferritinemia
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
05
12
2022
revised:
08
02
2023
accepted:
13
02
2023
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Adult-onset Still's disease (AOSD) is an uncommon inflammatory disorder. AOSD and SARS-Cov-2 infection share clinical and laboratory features, including systemic inflammation. A 19-year-old woman had prolonged fever for 3 weeks, joint pain, and biological inflammatory syndrome. Post COVID-19 AOSD was diagnosed. SARS-Cov-2 infection induces many inflammatory diseases including AOSD.
Identifiants
pubmed: 36873075
doi: 10.1002/ccr3.7006
pii: CCR37006
pmc: PMC9979958
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e7006Informations de copyright
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Immunother Cancer. 2021 May;9(5):
pubmed: 33963016
Medicine (Baltimore). 1991 Mar;70(2):118-36
pubmed: 2005777
Ann Rheum Dis. 1995 Jul;54(7):587-90
pubmed: 7668903
Eur Rev Med Pharmacol Sci. 2020 Dec;24(24):12627-12629
pubmed: 33378008
Lancet Rheumatol. 2021 May;3(5):e319-e321
pubmed: 33817663
J Rheumatol. 1992 Mar;19(3):424-30
pubmed: 1578458
Cell Discov. 2020 May 4;6:31
pubmed: 32377375
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Lancet Rheumatol. 2021 Apr;3(4):e253-e261
pubmed: 33655218
Drugs. 2008;68(3):319-37
pubmed: 18257609
Clin Med Insights Case Rep. 2021 Feb 19;14:1179547621996306
pubmed: 33679145
Lancet Rheumatol. 2020 Jun;2(6):e325-e331
pubmed: 32501454
Sci Rep. 2018 Jan 15;8(1):723
pubmed: 29335509